External Facilitation to Increase Presc… | Clinical Trial

Key information

Conditions

Alcohol-Related Disorders Chemically-Induced Disorders Mental Disorders Psychiatric Disorder Substance-Related Disorders

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Maryland Baltimore

Baltimore, Maryland, 21201, United States

Location status: Recruiting

Location contact

Brian Brandler

CONTACT

[email protected]

Melanie Bennett

CONTACT

[email protected]

410-706-0892

Melanie Bennett

PRINCIPAL_INVESTIGATOR

About this study

This project will pilot test an implementation facilitation intervention to increase prescribing of medications for alcohol use disorder (MAUD) in patients with major mental illness and alcohol use disorder in three psychiatry treatment clinics. Guided by the integrated Promoting Action on Research Implementation in Health Services framework, an external facilitator will work with each clinics' internal champion to (1) provide clinic level education on MAUD in non-specialty care settings, (2) provide clinic level training in using a standardized screen measure for alcohol use disorder, documenting screening results in the electronic health record, and documenting alcohol use disorder diagnosis in the electronic health record, (3) help internal champions use an audit and feedback system for weekly review of MAUD education and prescribing, (4) help internal champions do weekly care coordination for patients with major mental illness and alcohol use disorder, and (5) make educational materials on MAUD available on site to patients so they are informed about these treatment options. Internal champions and clinics will have access to consultation from a MAUD clinician expert. These activities will take place across pre-implementation and implementation phases and will be followed by a post-implementation facilitation sustainment period during which clinics and champions continue implementation on their own. Formative Evaluation activities will take place throughout; at the end of the sustainment phase, MAUD outcomes will be assessed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

For prescribers: working as a prescriber, non-prescribing clinician, or administrator at one of the three participating clinics.
For patients: has major mental illness (major depressive disorders, bipolar disorder, schizophrenia spectrum disorders, other psychotic disorders; posttraumatic stress disorder)
For patients: has Alcohol Use Disorder and is being treated in one of the three participating clinics.

Exclusion criteria

For all: age is less than 18 years old
For all: not able to complete informed consent

Treatment and study plan

Implementation Facilitation

Other

Implementation facilitation is a multi-faceted process of enabling and supporting the adoption and integration of best practices into routine clinical care. It involves collaboration to understand a setting's challenges and barriers and working together to identify the best activities to address them. IF will incorporate External Facilitation, a problem-solving implementation strategy that builds supportive interpersonal relationships between an External Facilitator who is outside of the clinic who works with clinics and their identified internal champions to learn their unique barriers to implementation, use strategies to address these barriers, and plan for sustainability by integrating the practice into routine processes and workflows. Other implementation activities that will be used IF include staff training, patient education, audit and feedback, and care coordination.

Primary outcomes

Prescribing medications for alcohol use disorder

Time frame: 6 months after the end of implementation facilitation

Change in the proportion of eligible patients prescribed a medication for alcohol use disorder in the clinic

Study contacts

Contact information is provided by the study sponsor or research team.

Brian Brandler

CONTACT

[email protected]

410-706-2490

Melanie Bennett, PhD

CONTACT

[email protected]

410-706-2490

Sponsors and collaborators

Lead sponsor

University of Maryland, Baltimore

Other

Registry information

Important dates

Study start: 2025
Primary completion: 2027
Study completion: 2027
First posted: Jul 8, 2025
Registry last updated: Jun 3, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed